Advertisement

Correction: High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma

August, 08, 2024 | Select Oncology Journal Articles

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –

Advertisement

LATEST

Advertisement

Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy